Cancer Research UK Signs Deal With Centella Therapeutics, Inc. to Launch Clinical Development of Radiotherapy-Enhancing Drug

Wednesday, May 25, 2011 General News
Email Print This Page Comment
Font : A-A+

Development and testing of new drug with potential to make radiation and/or chemotherapy more effective for certain resistant tumours

CRUK

Centella/Varian Medical Systems

Emma Rigby, 020 3469 8300

Meryl Ginsberg, 650-424-6444

Emma.Rigby@cancer.org.uk

meryl.ginsberg@varian.com



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Advertisement
Advertisement

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook